Synapse Open Synapse
Biology

South African Labs Strive for Africa’s Biopharma Sovereignty

GEN · · 5 min read

Africa still imports 99% of its routine vaccines and 70–90% of its biopharmaceuticals. The Africa CDC warns this vulnerability could cost the continent up to $1.1 trillion in skills and jobs through 2050.

Latest from GEN